Top

06-01-2025 | Type 2 Diabetes | Review Article

Unraveling the role of muscle mass and strength in predicting type 2 diabetes risk: a systematic review

Authors: Hans Putranata, Antoninus Hengky, Budhi Hartoko

Abstract

Introduction

Skeletal muscle is the largest insulin-sensitive tissue in the human body, alteration in muscle mass and strength substantially impact glucose metabolism. This systematic review aims to investigate further the relationship between muscle mass and strength towards type 2 diabetes mellitus (T2DM) incidence.

Methods

This systematic review included cohort studies that examinedthe relationship between muscle mass and/or muscle strength on T2DM incidence. A comprehensive search was conducted across PubMed, EBSCO, ProQuest, and Google scholar employing specific Medical Subject Headings (MeSH) and relevant keywords related to or synonymous with “muscle mass”, “muscle strength”, and “Type 2 Diabetes Mellitus incidence”.

Results

Twenty-five cohort studies were included, 11 studies on muscle mass and 16 studies on muscle strength. Participants included were 278,475 for muscle mass and 400,181 for muscle strength. Skeletal muscle mass normalized to body weight (SMM/BW), appendicular skeletal musce mass normalized to body weight (ASM/BW), and handgrip strength normalized to body mass index (HGS/BMI) consistently demonstrate significant inverse association with T2DM even after sex and/or BMI stratification. Handgrip strength normalized to body weight (HGS/BW) demonstrates a strong inverse association with T2DM incidence, however, adiposity should be considered.

Conclusion

Muscle mass and strength demonstrate strong association with T2DM incidence. Adiposity, a key T2DM risk factor, should also be assessed through a simple BMI or a sophisticated technique with BIA or CT-scan. The combination of muscle variables and adiposity could further enhance T2DM risk assessment. However, T2DM risks are multifactorial, with various contributing factors, further large-scale studies are needed to validate these findings.

Available only for authorised users

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21(17):6275. https://doi.org/10.3390/ijms21176275CrossRefPubMedPubMedCentral

Khan MAS, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J (2020) Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Glob Health 10:107–111. https://doi.org/10.2991/jegh.k.191028.001CrossRefPubMedPubMedCentral

Wu Y, Fu R, Lei C, Deng Y, Lou W, Wang L et al (2021) Estimates of type 2 diabetes mellitus burden attributable to particulate matter pollution and its 30-year change patterns: a systematic analysis of data from the global burden of disease study 2019. Front Endocrinol 12:689079. https://doi.org/10.3389/fendo.2021.689079CrossRef

Hong S, Chang Y, Jung H-S, Yun KE, Shin H, Ryu S (2017) Relative muscle mass and the risk of incident type 2 diabetes: a cohort study. PLoS ONE 12(11):e0188650. https://doi.org/10.1371/journal.pone.0188650CrossRefPubMedPubMedCentral

Dyar KA, Ciciliot S, Wright LE, Biensø RS, Tagliazucchi GM, Patel VR et al (2014) Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. Mol Metab 3:29–41. https://doi.org/10.1016/j.molmet.2013.10.005CrossRefPubMed

Bergman BC, Goodpaster BH (2020) Exercise and muscle lipid content, composition, and localization: influence on muscle insulin sensitivity. Diabetes 69(5):848–858. https://doi.org/10.2337/dbi18-0042CrossRefPubMed

Shou J, Chen PJ, Xiao WH (2020) Mechanism of increased risk of insulin resistance in aging skeletal muscle. Diabetol Metab Syndr 12:14. https://doi.org/10.1186/s13098-020-0523-xCrossRefPubMedPubMedCentral

Kawahito S, Kitahata H, Oshita S (2009) Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol 15(33):4137–4142. https://doi.org/10.3748/wjg.15.4137CrossRefPubMedPubMedCentral

Liu ZJ, Zhu CF (2023) Causal relationship between insulin resistance and sarcopenia. Diabetol Metab Syndr 15:46. https://doi.org/10.1186/s13098-023-01022-zCrossRefPubMedPubMedCentral

10.

Abd.Ghafar MZA, O’Donovan M, Sezgin D, Moloney E, Rodríguez-Laso Á, Liew A et al (2022) Frailty and diabetes in older adults: overview of current controversies and challenges in clinical practice. Front Clin Diabetes Healthc 3:895313. https://doi.org/10.3389/fcdhc.2022.895313CrossRefPubMedPubMedCentral

11.

Haines MS, Leong A, Porneala BC, Meigs JB, Miller KK (2022) Association between muscle mass and diabetes prevalence independent of body fat distribution in adults under 50 years old. Nutr Diabetes 12:29. https://doi.org/10.1038/s41387-022-00204-4CrossRefPubMedPubMedCentral

12.

Riviati N, Indra B (2023) Relationship between muscle mass and muscle strength with physical performance in older adults: a systematic review. SAGE Open Med 11:1–3. https://doi.org/10.1177/20503121231214650CrossRef

13.

Kuschel LB, Sonnenburg D, Engel T (2022) Factors of muscle quality and determinants of muscle strength: a systematic literature review. Healthc (Basel) 10(10):1937. https://doi.org/10.3390/healthcare10101937CrossRef

14.

Yoshiko A, Shiozawa K, Niwa S, Takahashi H, Koike T, Watanabe K et al (2023) Association of skeletal muscle oxidative capacity with muscle function, Sarcopenia-related exercise performance, and intramuscular adipose tissue in older adults. GeroScience 46(2):2715–2727. https://doi.org/10.1007/s11357-023-01043-6CrossRefPubMedPubMedCentral

15.

Lee SY (2021) Handgrip strength: an irreplaceable indicator of muscle function. Ann Rehabil Med 45(3):167–169. https://doi.org/10.5535/arm.21106CrossRefPubMedPubMedCentral

16.

Lopez-Pedrosa JM, Camprubi-Robles M, Guzman-Rolo G, Lopez-Gonzalez A, Garcia-Almeida JM, Sanz-Paris A et al (2024) The vicious cycle of type 2 diabetes mellitus and skeletal muscle atrophy: clinical, biochemical, and nutritional bases. Nutrients 16(1):172. https://doi.org/10.3390/nu16010172CrossRefPubMedPubMedCentral

17.

Lu Z, Hu Y, He H, Chen X, Ou Q, Liu Y et al (2024) Associations of muscle mass, strength, and quality with diabetes and the mediating role of inflammation in two national surveys from China and the United States. Diabetes Res Clin Pract 214:111783. https://doi.org/10.1016/j.diabres.2024.111783CrossRefPubMed

18.

Wu H, Gu Y, Wang X, Meng G, Rayamajhi S, Thapa A et al (2023) Association between handgrip strength and type 2 diabetes: a prospective cohort study and systematic review with meta-analysis. J Gerontol Biol Sci Med Sci 78(8):1383–1391. https://doi.org/10.1093/gerona/glac241CrossRef

19.

Suárez R, Andrade C, Bautista-Valarezo E, Sarmiento-Andrade Y, Matos A, Jimenez O et al (2024) Low muscle mass index is associated with type 2 diabetes risk in a latin-american population: a cross-sectional study. Front Nutr 11:1448834. https://doi.org/10.3389/fnut.2024.1448834CrossRefPubMedPubMedCentral

20.

Lee MR, Jung SM, Bang H, Kim HS, Kim YB (2018) Association between muscle strength and type 2 diabetes mellitus in adults in Korea. Med (Baltim) 97:e10984. https://doi.org/10.1097/MD.0000000000010984CrossRef

21.

Katzmarzyk PT, Craig CL, Gauvin L (2007) Adiposity, physical fitness and incident diabetes: the physical activity longitudinal study. Diabetologia 50:538–544. https://doi.org/10.1007/s00125-006-0554-3CrossRefPubMed

22.

Wander PL, Boyko EJ, Leonetti DL, McNeely MJ, Kahn SE, Fujimoto WY (2011) Greater hand-grip strength predicts a lower risk of developing type 2 diabetes over 10 years in leaner Japanese americans. Diabetes Res Clin Pract 92(2):261–264. https://doi.org/10.1016/j.diabres.2011.01.007CrossRefPubMedPubMedCentral

23.

Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A, Orlandini A et al (2015) Prognostic value of grip strength: findings from the prospective urban rural epidemiology (PURE) study. Lancet 386(9990):266–273. https://doi.org/10.1016/S0140-6736(14)62000-6CrossRefPubMed

24.

Cuthbertson DJ, Bell JA, Ng SY, Kemp GJ, Kivimaki M, Hamer M (2016) Dynapenic obesity and the risk of incident type 2 diabetes: the English longitudinal study of ageing. Diabet Med 33(8):1052–1059. https://doi.org/10.1111/dme.12991CrossRefPubMed

25.

Larsen BA, Wassel CL, Kritchevsky SB, Strotmeyer ES, Criqui MH, Kanaya AM et al (2016) Association of muscle mass, area, and strength with incident diabetes in older adults: the health ABC study. J Clin Endocrinol Metab 101(4):1847–1855. https://doi.org/10.1210/jc.2015-3643CrossRefPubMedPubMedCentral

26.

Li JJ, Wittert GA, Vincent A, Atlantis E, Shi Z, Appleton SL et al (2016) Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metabolism 65(6):883–892. https://doi.org/10.1016/j.metabol.2016.03.011CrossRefPubMed

27.

Marques-Vidal P, Vollenweider P, Waeber G, Jornayvaz FR (2017) Grip strength is not associated with incident type 2 diabetes mellitus in healthy adults: the CoLaus study. Diabetes Res Clin Pract 132:144–148. https://doi.org/10.1016/j.diabres.2017.08.004CrossRefPubMed

28.

McGrath R, Vincent BM, Snih SA, Markides KS, Peterson MD (2017) The association between muscle weakness and incident diabetes in older Mexican americans. J Am Med Dir Assoc 18(5):452e. 7-452.e12CrossRef

29.

Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY et al (2017) Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia 60:865–872. https://doi.org/10.1007/s00125-016-4196-9CrossRefPubMed

30.

Han SJ, Boyko EJ, Kim SK, Fujimoto WY, Kahn SE, Leonetti DL (2018) Association of thigh muscle mass with insulin resistance and incident type 2 diabetes mellitus in Japanese americans. Diabetes Metab J 42(6):488–495. https://doi.org/10.4093/dmj.2018.0022CrossRefPubMedPubMedCentral

31.

Karvonen-Gutierrez CA, Peng Q, Peterson M, Duchowny K, Nan B, Harlow S (2018) Low grip strength predicts incident diabetes among mid-life women: the michigan study of women’s health across the nation. Age Ageing 47(5):685–691. https://doi.org/10.1093/ageing/afy067CrossRefPubMedPubMedCentral

32.

Baker CF, Overvad K, Dahm CC (2019) Lean body mass and risk of type 2 diabetes - a Danish cohort study. J Diabetes Metab Disord 18(2):445–451. https://doi.org/10.1007/s40200-019-00438-7CrossRefPubMedPubMedCentral

33.

Maliszewska K, Adamska-Patruno E, Goscik J, Lipinska D, Citko A, Krahel A et al (2019) The role of muscle decline in type 2 diabetes development: a 5-year prospective observational cohort study. Nutrients 11(4):834. https://doi.org/10.3390/nu11040834CrossRefPubMedPubMedCentral

34.

Momma H, Sawada SS, Kato K, Gando Y, Kawakami R, Miyachi M et al (2019) Physical fitness tests and type 2 diabetes among Japanese: a longitudinal study from the Niigata wellness study. J Epidemiol 29(4):139–146. https://doi.org/10.2188/jea.JE20170280CrossRefPubMedPubMedCentral

35.

Kalyani RR, Metter EJ, Xue QL, Egan JM, Chia CW, Studenski S et al (2020) The relationship of lean body mass with aging to the development of diabetes. J Endocr Soc 4(7):bvaa043. https://doi.org/10.1210/jendso/bvaa043CrossRefPubMedPubMedCentral

36.

Kunutsor SK, Voutilainen A, Laukkanen JA (2020) Handgrip strength improves prediction of type 2 diabetes: a prospective cohort study. Ann Med 52(8):471–478. https://doi.org/10.1080/07853890.2020.1815078CrossRefPubMedPubMedCentral

37.

Boonpor J, Parra-Soto S, Petermann-Rocha F, Ferrari G, Welsh P, Pell JP et al (2021) Associations between grip strength and incident type 2 diabetes: findings from the UK biobank prospective cohort study. BMJ Open Diab Res Care 9:e001865. https://doi.org/10.1136/bmjdrc-2020-001865CrossRefPubMedPubMedCentral

38.

Buscemi C, Ferro Y, Pujia R, Mazza E, Boragina G, Sciacqua A et al (2021) Sarcopenia and appendicular muscle mass as predictors of impaired fasting glucose/type 2 diabetes in elderly women. Nutrients 13:1909. https://doi.org/10.3390/nu13061909CrossRefPubMedPubMedCentral

39.

Jeon YJ, Lee SK, Shin C (2021) Normalized hand grip and back muscle strength as risk factors for incident type 2 diabetes mellitus: 16 years of follow-up in a population-based cohort study. Diabetes Metab Syndr Obes 14:741–750. https://doi.org/10.2147/DMSO.S283853CrossRefPubMedPubMedCentral

40.

LeCroy MN, Hua S, Kaplan RC, Sotres-Alvarez D, Qi Q, Thyagarajan B et al (2021) Associations of changes in fat free mass with risk for type 2 diabetes: hispanic community health study/study of latinos. Diabetes Res Clin Pract 171:108557. https://doi.org/10.1016/j.diabres.2020.108557CrossRefPubMed

41.

Xu Y, Hu T, Shen Y, Wang Y, Bao Y, Ma X (2023) Association of skeletal muscle mass and its change with diabetes occurrence: a population-based cohort study. Diabetol Metab Syndr 15:53. https://doi.org/10.1186/s13098-023-01027-8CrossRefPubMedPubMedCentral

42.

He YY, Jin ML, Fang XY, Wang XJ (2024) Associations of muscle mass and strength with new-onset diabetes among middle-aged and older adults: evidence from the China health and retirement longitudinal study (CHARLS). Acta Diabetol. https://doi.org/10.1007/s00592-024-02265-6CrossRefPubMedPubMedCentral

43.

Lee SB, Jo MK, Moon JE, Lee HJ, Kim JK (2024) Relationship between handgrip strength and incident diabetes in Korean adults according to gender: a population-based prospective cohort study. J Clin Med 13:627. https://doi.org/10.3390/jcm13020627CrossRefPubMedPubMedCentral

44.

Kyle UG, Bosaeus I, Lorenzo ADD, Deurenberg P, Elia M, Gómez JM et al (2004) Bioelectrical impedance analysis—part I: review of principles and methods. Clin Nutr 23(5):1226–1243. https://doi.org/10.1016/j.clnu.2004.06.004CrossRefPubMed

45.

Shepherd J, Ng B, Sommer M, Heymsfield SB (2017) Body composition by DXA. Bone 104:101–105. https://doi.org/10.1016/j.bone.2017.06.010CrossRefPubMedPubMedCentral

46.

Tolonen A, Pakarinen T, Sassi A, Kyttä J, Cancino W, Rinta-Kiikka I et al (2021) Methodology, clinical applications, and future directions of body composition analysis using computed tomography (CT) images: a review. Eur J Radiol 145:109943. https://doi.org/10.1016/j.ejrad.2021.109943CrossRefPubMed

47.

Chaves LGCDM, Gonçalves TJM, Bitencourt AGV, Rstom RA, Pereira TR, Velludo SF (2022) Assessment of body composition by whole-body densitometry: what radiologists should know. Radiol Bras 55(5):305–311. https://doi.org/10.1590/0100-3984.2021.0155-enCrossRefPubMedPubMedCentral

48.

Bosy-Westphal A, Jensen B, Braun W, Pourhassan M, Gallagher D, Müller MJ (2017) Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices. Eur J Clin Nutr 71:1061–1067. https://doi.org/10.1038/ejcn.2017.27CrossRefPubMedPubMedCentral

49.

Zachariah VK, Priyamvada PS (2023) Bioimpedance analysis: basic concepts. J Ren Nutr Metab 8(1):30–34. https://doi.org/10.4103/JRNM.JRNM_9_23CrossRef

50.

Brown JC, Harhay MO, Harhay MN (2017) Appendicular lean mass and mortality among prefrail and frail older adults. J Nutr Health Aging 21(3):342–345. https://doi.org/10.1007/s12603-016-0753-7CrossRefPubMedPubMedCentral

51.

Lee SW, Youm Y, Lee WJ, Choi W, Chu SH, Park YR et al (2015) Appendicular skeletal muscle mass and insulin resistance in an elderly Korean population: the Korean social life, health and aging project-health examination cohort. Diabetes Metab J 39(1):37–45. https://doi.org/10.4093/dmj.2015.39.1.37CrossRefPubMedPubMedCentral

52.

Balakrishnan R, Thurmond DC (2022) Mechanisms by which skeletal muscle myokines ameliorate insulin resistance. Int J Mol Sci 23(9):4636. https://doi.org/10.3390/ijms23094636CrossRefPubMedPubMedCentral

53.

Kirichenko TV, Markina YV, Bogatyreva AI, Tolstik TV, Varaeva YR, Starodubova AV (2022) The role of adipokines in inflammatory mechanisms of obesity. Int J Mol Sci 23(23):14982. https://doi.org/10.3390/ijms232314982CrossRefPubMedPubMedCentral

54.

Chung HS, Choi KM (2018) Adipokines and myokines: a pivotal role in metabolic and cardiovascular disorders. Curr med chem 25(20):2401–2415. https://doi.org/10.2174/0929867325666171205144627CrossRefPubMed

55.

Dondero K, Friedman B, Rekant J, Landers-Ramos R, Addison O (2024) The effects of myosteatosis on skeletal muscle function in older adults. Physiol Rep 12(9):e16042. https://doi.org/10.14814/phy2.16042CrossRefPubMedPubMedCentral

56.

Gilbert M (2021) Role of skeletal muscle lipids in the pathogenesis of insulin resistance of obesity and type 2 diabetes. J Diabetes Investig 12(11):1934–1941. https://doi.org/10.1111/jdi.13614CrossRefPubMedPubMedCentral

57.

Kim JA, Wei Y, Sowers JR (2008) Role of mitochondrial dysfunction in insulin resistance. Circ Res 102(4):401–414. https://doi.org/10.1161/CIRCRESAHA.107.165472CrossRefPubMedPubMedCentral

58.

Wang L, Valencak TG, Shan T (2024) Fat infiltration in skeletal muscle: influential triggers and regulatory mechanism. iScience 27(3):109221. https://doi.org/10.1016/j.isci.2024.109221CrossRefPubMedPubMedCentral

59.

Ahn H, Kim DW, Ko Y, Ha J, Shin YB, Lee J et al (2021) Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond Sarcopenia. Ageing Res Rev 70:101398. https://doi.org/10.1016/j.arr.2021.101398CrossRefPubMed

60.

Kato M, Okada Y, Nakano W, Takagi D, Ochi M, Ohyagi Y et al (2023) Bioimpedance phase angle is independently associated with myosteatosis: the shizuoka study. Clin Nutr 42(5):793–799. https://doi.org/10.1016/j.clnu.2023.03.016CrossRefPubMed

61.

Chianca V, Albano D, Messina C, Gitto S, Ruffo G, Guarino S et al (2022) Sarcopenia: imaging assessment and clinical application. Abdom Radiol 47:3205–3216. https://doi.org/10.1007/s00261-021-03294-358CrossRef

62.

Soraya N, Parwanto E (2023) The controversial relationship between body mass index and handgrip strength in the elderly: an overview. Malays J Med Sci 30(3):73–83. https://doi.org/10.21315/mjms2023.30.3.6CrossRefPubMedPubMedCentral

63.

Artasensi A, Mazzolari A, Pedretti A, Vistoli G, Fumagalli L (2023) Obesity and type 2 diabetes: adiposopathy as a triggering factor and therapeutic options. Molecules 28(7):3094. https://doi.org/10.3390/molecules28073094CrossRefPubMedPubMedCentral

64.

Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontés G (2010) Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 1801:289–298. https://doi.org/10.1016/j.bbalip.2009.08.006CrossRefPubMed

65.

Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW et al (2020) Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest 130(3):1453–1460. https://doi.org/10.1172/JCI134165CrossRefPubMedPubMedCentral

66.

Kiefer LS, Fabian J, Rospleszcz S, Lorbeer R, Machann J, Kraus MS et al (2021) Distribution patterns of intramyocellular and extramyocellular fat by magnetic resonance imaging in subjects with diabetes, prediabetes and normoglycaemic controls. Diabetes Obes Metab 23:1868–1878. https://doi.org/10.1111/dom.14413CrossRefPubMed

67.

Klein S, Gastaldelli A, Yki-Järvinen H, Scherer PE (2022) Why does obesity cause diabetes? Cell Metab 34(1):11–20. https://doi.org/10.1016/j.cmet.2021.12.012CrossRefPubMedPubMedCentral

68.

Jayedi A, Soltani S, Motlagh SZ-T, Emadi A, Shahinfar H, Moosavi H et al (2022) Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ 376:e067516. https://doi.org/10.1136/bmj-2021-067516CrossRefPubMedPubMedCentral

69.

Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R et al (2012) Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308(11):1150–1159. https://doi.org/10.1001/2012.jama.11132CrossRefPubMedPubMedCentral

70.

Shen F, Guo C, Zhang D, Liu Y, Zhang P (2024) Visceral adiposity index as a predictor of type 2 diabetes mellitus risk: a systematic review and dose–response meta-analysis. Nutr Metab Cardiovasc Dis 34(4):811–822. https://doi.org/10.1016/j.numecd.2023.04.009CrossRefPubMed

71.

Kim K, Park SM (2018) Association of muscle mass and fat mass with insulin resistance and the prevalence of metabolic syndrome in Korean adults: a cross-sectional study. Sci Rep 8:2703. https://doi.org/10.1038/s41598-018-21168-5CrossRefPubMedPubMedCentral

72.

Barrett M, McClure R, Villani A (2020) Adiposity is inversely associated with strength in older adults with type 2 diabetes mellitus. Eur Geriatr Med 11:451–458. https://doi.org/10.1007/s41999-020-00309-yCrossRefPubMed

73.

Ritter RD, Sep SJS, Greevenbroek MMJV, Kusters YHAM, Vos RC, Bots ML et al (2023) Sex differences in body composition in people with prediabetes and type 2 diabetes as compared with people with normal glucose metabolism: the maastricht study. Diabetologia 66(5):861–872. https://doi.org/10.1007/s00125-023-05880-0CrossRefPubMedPubMedCentral

74.

Dhokte S, Czaja K (2024) Visceral adipose tissue: the hidden culprit for type 2 diabetes. Nutrients 16(7):1015. https://doi.org/10.3390/nu16071015CrossRefPubMedPubMedCentral

75.

Peterson MD, Snih SA, Serra-Rexach JA, Burant C (2015) Android adiposity and lack of moderate and vigorous physical activity are associated with insulin resistance and diabetes in aging adults. J Gerontol Biol Sci Med Sci 70(8):1009–1017. https://doi.org/10.1093/gerona/glv002CrossRef

76.

Ding L, Fan Y, He J, Wang R, He Q, Cui J (2021) Different indicators of adiposity and fat distribution and cardiometabolic risk factors in patients with type 2 diabetes. Obes (Silver Spring) 29(5):837–845. https://doi.org/10.1002/oby.23151CrossRef

Title: Unraveling the role of muscle mass and strength in predicting type 2 diabetes risk: a systematic review
Authors: Hans Putranata
Antoninus Hengky
Budhi Hartoko
Publication date: 06-01-2025
Publisher: Springer Milan
Keywords: Type 2 Diabetes
Insulins
Insulins
Obesity
Obesity
Published in: Acta Diabetologica
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-024-02440-9

Keynote webinar | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now

Keynote webinar | Spotlight on adolescent vaping

Live
Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET

Prof. Ann McNeill

Dr. Debbie Robson

Benji Horwell

Developed by: Springer Medicine

Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty in Geriatric Patients
On-demand webinar

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft

Prof. Barbara C. van Munster

Prof. Mirko Petrovic

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Keynote webinar | Spotlight on menopause

Keynote webinar | Spotlight on adolescent vaping

Keynote webinar | Spotlight on modern management of frailty

A quick guide to ECGs

At a glance: The STEP trials